ukmla MCQ (SBA): Graves' disease

Instant feedback + full explanation. One question, done properly.

MediumEndocrinologyGraves' diseaseukmlamrcp part 1

A 35-year-old patient with new Graves' disease and mild eye signs is started on carbimazole. What is a common serious adverse effect requiring monitoring?

Educational content. Not a substitute for clinical judgement or local policy.